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Introduction
Two  genetically  modified  trees  (GMTs) 
have  been  commercialised  outside  Europe 
and the application of genetic modification 
techniques to trees is currently at an advan-
ced stage of research in the EU, with experi-
mental  field  trials  in  some  countries 
(Fladung 2011, Walter et al. 2010). Traits in-
troduced  to  GMTs include  modification  of 
lignin and cellulose composition,  optimised 
biomass for biofuel production and resistan-
ce to pests and diseases, among others (Har-
fouche et al. 2011,  2012). Hence, GM tech-
nology is expected to be part of the toolbox 
for the future breeding of trees for agricul-
ture and forestry use.
Apart from the expected benefits, the cul-
tivation and use of GMTs may have environ-
ment  impacts where the GMT and its  pro-
ducts  are  released.  These  impacts  can  be 
caused  by  the  new  trait  conferred  to  the 
GMT and/or by the recombinant DNA/trans-
genes introduced. For instance, if the trans-
genes are not  part  of the gene pool  of the 
tree species and they transfer to wild coun-
terparts,  relatives  or  to  other  species,  they 
may impact other  biota  and ecosystems.  In 
addition, the genetic modification might lead 
to unintended changes in the characteristics 
of the modified tree that can also affect the 
environment. If the intended use of the GMT 
is agricultural (e.g., fruit trees) there is also a 
potential for changes to the food safety cha-
racteristics of the products derived from it.
Different national and international autho-
rities have established regulations to ensure 
the  safe  use  of  GMOs,  including  GMTs 
(Kikuchi et al. 2008). In addition, there are 
internationally  agreed  standards  (OECD 
2012a, Codex Alimentarius 2009) on how to 
assess the potential health and environmental 
risks caused by such organisms. In the Euro-
pean Union (EU), different legal documents 
regulate all aspects related to GMOs inclu-
ding their safety assessment, labelling, mar-
keting,  transport,  sampling  and  detection, 
and  post-market  environmental  monitoring. 
In  accordance with relevant legislation,  the 
European Food Safety Authority (EFSA) as-
sesses  all  GMO applications  for  marketing 
and or cultivation in the EU. Here we review 
the  existing  regulatory  framework  and  the 
principles  governing the risk assessment  of 
GM plants in the EU, with special focus on 
GMTs. We highlight particularities of GMT 
that may require particular considerations in 
the  assessment,  and  for  which  further  gui-
dance might be needed.
Regulatory framework
Among the existing legal  mechanisms af-
fecting GMOs in the EU, there are two legis-
lations  that  focus  specifically on  safety is-
sues. These are Directive 2001/18/EC on the 
deliberate  release  into  the  environment  of 
GMOs (EC 2001) hereafter referred to as the 
“GMO Directive”, and Regulation (EC) No 
1829/2003 on genetically modified food and 
feed (EC 2003), the “GM FF Regulation”[1]. 
For GM plants such as trees, the scope of the 
GMO Directive includes environmental safe-
ty issues derived from cultivation practices, 
but  also covers other cases of (unintended) 
release as a consequence of the transport and 
processing  of  seeds  or  other  parts  of  the 
plant.  The  GM  FF  Regulation  attends  to 
food  and  feed  consisting  of,  containing  or 
derived  from GM plants,  and  covers  food 
and  feed  safety issues,  as  well  as  environ-
mental risks potentially posed by such food 
and feed.
As common principals,  these two legisla-
tions establish that in the EU, products that 
are,  contain,  or  are  produced  from GMOs 
must:  (i)  be subjected  to  a  risk assessment 
prior  to  authorisation;  (ii)  be  safe  for  hu-
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The use of genetically modified organisms - their release into the environment, 
import, and utilisation as food/feed or food/feed ingredients - is regulated in 
the European Union (EU). For placing onto the market, current legislations re-
quire a comprehensive and science-based risk assessment. This risk assessment 
(RA) is performed by applicants and then evaluated by national authorities in 
close cooperation with the European Food Safety Authority (EFSA). The EFSA 
Panel on Genetically Modified Organisms (GMO) has published a comprehensive 
set of guidance documents for applicants and risk assessors for the RA of GM 
plants (GMP), their products for food and/or feed use, and their cultivation. In 
those documents, the strategy and the criteria to conduct the assessment are 
explained, as well as the scientific data to be provided by the applicant. The 
assessment starts with the molecular characterisation of the GMP. If the GMP 
or products derived from it are to be consumed, the evaluation of its composi-
tion, potential  toxicity and/or allergenicity,  and nutritional value constitute 
further cornerstones of the process. The environmental risk assessment (ERA) 
considers biotic and abiotic interactions and the impacts of the management of 
the GM plant when it is intended for cultivation. In the case of GM trees special 
emphasis would be placed on assessing their characteristic features such as 
their longevity, ability to disperse and their ecological significance in a range 
of environments. The outcome of the assessment is reflected in a published 
opinion from the EFSA GMO panel  that  indicates  whether the GMP and  its 
products raise any safety issues. This scientific opinion constitutes one of the 
elements taken into account by the different European regulatory authorities 
prior to a decision regarding authorisation to commercialise the product.
Keywords: GM Trees, Genetically Modified, Transgenic, Recombinant DNA, Risk 
Identification, Risk Characterization, Exposure Assessment
Aguilera J et al. - iForest 6: 127-131 
mans, animals and the environment; and (iii) 
gain an authorisation  to  be placed into  the 
market. Those who intend to release or mar-
ket a GM plant or derived product must sub-
mit an application, being the main part of it a 
dossier  that  compiles  all  the  scientific  data 
necessary to characterise the risks, followed 
by a safety assessment. Then, EFSA and the 
Competent  Authorities  of  Member  States 
(MSs)  undertake  a  re-evaluation  of  the  in-
formation and the assessment  submitted by 
the applicant. If the GM plant in question is 
intended to be both cultivated and used for 
food/feed  purposes,  a  single  application 
under the GM FF Regulation, containing all 
the data requested by both legislations, will 
be  enough  to  pursue  authorisation  under 
both  the  GMO  Directive  and  the  GMFF 
Regulation.  Authorisations are valid  for 10 
years. After this period, permit holders must 
submit  a new application (including a new 
dossier,  which  will  be  again  evaluated)  in 
order  to  pursue  a  renewal  for  another  10 
years.
Cultivation of GMTs for non-food and  
feed purposes 
The use  of  GMTs for  forestry and  other 
purposes not involving food or feed is regu-
lated  by the  GMO Directive  as  mentioned 
above. The Directive considers two types of 
deliberate  releases:  those  for  placing  the 
product on the EU market (e.g., cultivation) 
and  those  for  experimental  purposes  (field 
trials). In the latter case, both the assessment 
of the application and the authorisation oc-
cur at national level only, and will not be co-
vered in this review.
In case of cultivation (or of any other way 
of placing the GMT in the market), applica-
tions must include an must include an envi-
ronmental  risk  assessment  (ERA),  whose 
structure is outlined in the Directive.  EFSA 
(2009) has provided specific guidance to ap-
plicants on the “ERA” of the cultivation of 
plants for non-food/feed use which comple-
ments the guidance for the risk assessment of 
the  cultivation  of plants  for  food  and  feed 
use (EFSA 2010) and the Guidance on the 
risk assessment of GM plants  for food and 
feed (EFSA 2011a). These documents provi-
de detailed guidance on the data required for 
the ERA of GM plants intended for cultiva-
tion (see below). Applications must be sub-
mitted  to  a  MS.  The  Competent  Authority 
(CA)  of  this  MS  assesses  the  application, 
with the possibility to request to the appli-
cant additional information it  deems neces-
sary to  complete  the  evaluation.  Then,  the 
MS issues an assessment report on whether 
the  GMO should  be  placed  on  the  market 
and under which conditions. This MS report 
is  distributed  by the  EC to  all  other  MSs, 
who can raise comments or reasoned objec-
tions. If there are no objections or the objec-
tions can be solved between the MSs them-
selves, then the MS who received the appli-
cation takes a decision on the authorisation, 
which would apply to the rest of the MSs by 
mutual recognition. In case of reasoned ob-
jections that cannot be resolved between the 
MSs, the application is forwarded to EFSA, 
who  conducts  a  further  assessment  and  is-
sues  an  opinion  on  the  safety of  the  GM 
plant.  EFSA is  also empowered  to  ask the 
applicant for further information as needed. 
Finally, EFSA issues a scientific opinion on 
the  ERA,  which  is  sent,  together  with  the 
initial ERA report of the lead MS, opinions 
and comments of the MS, to the European 
Commission (DG SANCO). The opinion is 
then considered by the EC, who (assisted by 
the MSs) decides on whether to authorise the 
cultivation of the GMT.
Cultivation of GMTs for food/feed 
purposes
When the GMT or its products are destined 
to enter the food chain (e.g., fruits), applica-
tions should be submitted under the GM FF 
Regulation.  In  addition  to  the  ERA,  such 
dossiers  must  also  contain  a  safety assess-
ment of the food and/or  feed derived from 
the GMT. In this case, the application is for-
warded directly to EFSA, who delegates to 
one MS the task to do the initial evaluation 
of the ERA submitted in the dossier. In addi-
tion, EFSA makes the full application avail-
able to all MSs for comments. Then, taking 
into account the assessment report of the de-
legated MS and all  the  comments  received 
from the  MSs,  EFSA  performs  an  assess-
ment  of  the  application  that  covers  both 
food/feed  and  environmental  safety  issues, 
and publishes its scientific opinion with its 
conclusions.  All opinions of the EFSA Pa-
nels are published and freely available in the 
EFSA  journal  (http://www.efsa.europa.eu/ 
en/publications/efsajournal.htm).  Likewise 
for non-food/feed cases, the EFSA opinion is 
considered by the EC and the MSs for their 
decision  on  whether  to  authorise  the GMT 
for both cultivation and food/feed use.
Key principles of the GMO risk 
assessment
The principles of risk assessment of GMOs 
and the different steps in the ERA are out-
lined  in  the GMO Directive and its imple-
menting guidelines (EC 2002). The starting 
point of the ERA is the identification of the 
characteristics of the GMO that are different 
from the corresponding non-modified orga-
nism  (conventional  counterpart),  and  the 
evaluation of the potential adverse effects of 
such  differences.  This  principle,  known  as 
the comparative approach, is internationally 
accepted  as  a  useful  starting  point  for  the 
risk  assessment  of  GMOs  (OECD  2012a). 
The  ERA  should  also  be  transparent  and 
scientifically sound,  i.e., based on scientific 
evidence  obtained  through  experiments, 
from laboratory tests to field trials. All un-
certainties identified and assumptions made 
should be clearly stated. Moreover, the ERA 
should  be  conducted  case-by-case,  taking 
into account the particularities of each GMO 
and its intended uses, which will  determine 
the  nature  and  extent  of  the  information 
needed.  Finally,  the  ERA should  take into 
account  direct,  indirect,  immediate  and de-
layed effects of the GMO, as well as cumu-
lative  long-term  effects,  which  would  be 
caused by the accumulation of effects during 
long periods of time.
The six steps of the ERA
Based  on  the  above  principles,  the  ERA 
should be constructed following six steps:
(1) identification of the characteristics of the 
GMO,  which  may cause  adverse  effects 
(hazard identification);
(2) evaluation of the potential  consequences 
of each adverse effect (hazard characteri-
sation);
(3) evaluation of the likelihood of the occur-
rence of each potential adverse effect (ex-
posure assessment);
(4) estimation of the risk posed by each iden-
tified  characteristic  (risk  characterisa-
tion);
(5) application of management strategies for 
the characterised risks, and
(6) determination  of  the  overall  risk  of  the 
GMO.
After  conducting  the  ERA,  the  applicant 
should  conclude  on  the  potential  environ-
mental impact of the GMO, in terms of in-
vasiveness,  gene  transfer,  effects  on  target 
and not-target organisms, effects on humans, 
animals, and biogeochemical processes, and 
impacts on cultivation and crop management 
techniques.
Available guidance in the EU
In order to provide details on how the risk 
assessment  of  GM  plants  should  be  per-
formed  by  the  applicant,  the  EFSA  GMO 
Panel  has  produced  a  set  of  guidance  do-
cuments that cover in detail different aspects 
of  the  assessment,  identify  methodolo- 
gy and  criteria  to  be  followed,  and  provi- 
de  rationales  for  the  data  requirements 
(http://www.efsa.europa.eu/en/gmo/gmoguid
ance.htm).  The  most  relevant  are  the  Gui-
dance on the environmental risk assessment 
of  GM plants  (EFSA 2010),  the  Guidance 
for  risk  assessment  of  food  and  feed  from 
GM plants (EFSA 2011a); and the Guidance 
on the ERA of the cultivation of GM plants 
for  non-food/feed  purposes  (EFSA  2009), 
which are developed to support in the pre-
paration and evaluation of applications.
Guidance documents on the environ-
mental risk assessment of GM plants for 
cultivation
These  documents  (EFSA  2009,  2010), 
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hereafter referred as the “ERA Guidances”, 
provide guidance for assessing the potential 
effects of GM plants on the environment via 
their cultivation and also through the trans-
port and processing of imported plant mate-
rial  not  cultivated  in  the  EU.  These  Gui-
dances are relevant for GM tree applications 
under the GMO Directive, and also for ap-
plications submitted under the GM FF Regu-
lation if the GM tree and its products are in-
tended for food/feed uses and for plant-de-
rived products and timber products such as 
chemicals, biofuels or paper.
Seven areas of concern in the ERA
Based on the potential risks outlined in the 
GMO Directive,  the  ERA Guidance  docu-
ment identifies seven specific areas of con-
cern  to  be  addressed  in  the  assessment, 
which are as follows:
(1) persistence  and  invasiveness  including 
plant-to-plant gene flow;
(2) plant to microorganisms gene transfer;
(3) interactions of the GM plant  with target 
organisms;
(4) interactions of the GM plant with non-tar-
get organisms (NTO);
(5) impacts on the specific cultivation, mana-
gement and harvesting techniques;
(6) effects on biogeochemical processes;
(7) effects on human and animal health.
Each specific area of concern is developed 
in a structured and systematic way through 
the six steps of the ERA as described in the 
GMO Directive (see above); with indications 
on the information to be provided. In addi-
tion, the ERA guidance document considers 
cross-cutting issues to be taken into account 
in a horizontal manner during the assessment 
of each area of concern. These issues include 
the choice of the comparator (non-modified 
plant), the receiving environment(s), the sta-
tistical principles for the analyses, the long-
term effects,  and  the  particularities  of  GM 
plants  containing  stacked  transformation 
events, for cases where relevant.
Guidance for risk assessment of food  
and feed from GM plants
This  document  hereafter  named  the  “FF 
Guidance” is focused on food and feed con-
sisting of,  containing,  or  derived from GM 
plants, and is relevant for applications under 
the GM FF Regulation.  Some parts of this 
document  are also relevant for the ERA of 
the GM plants, such as the molecular charac-
terisation  of  the  genetic  modification,  and 
the  compositional,  phenotypic  and  agrono-
mic analyses.  Cross-references between the 
two  documents  are  provided  where  neces-
sary.
The  FF  Guidance  presents  in  depth  the 
general principles of the risk assessment of 
GM plants and how they should be applied 
for  products  within  its  scope.  As  for  the 
ERA,  the  comparative  approach  is  recog-
nised as the best principle for the safety as-
sessment  of  GM  plant-derived  food/feed 
products. This principle should therefore be 
applied  for  the  assessment  of  the  intended 
effects of the genetic modification, and also 
for the detection and evaluation of any pos-
sible unintended effects. The document also 
provides guidance on the choice of the ap-
propriate  comparator.  In  addition  to  this 
comparator,  the  FF  Guidance  recommends 
the use of a set of commercial non-GM refe-
rence varieties, in order to estimate the range 
of natural variation of the different endpoints 
to be compared. The compositional and phe-
notypic parameters to be analysed are descri-
bed in detail, as well as the optimal design of 
the field trials and the statistical tests to be 
applied for the comparisons. For cases where 
the comparative approach is not possible, al-
ternative  strategies  are  proposed.  Particular 
guidance is also given on how to structure 
the assessment of stacked events, including 
sub-combinations of events in cases where 3 
or  more unlinked  inserts are present  in  the 
GM plant.
The FF Guidance covers all aspects of the 
safety of food and feed products that should 
be  evaluated,  such  as  potential  changes  in 
toxicity,  allergenicity,  and  nutritional  com-
position. Animal feeding trials for toxicolo-
gical studies are recommended on a case-by-
case basis, depending of the outcome of the 
molecular characterisation and the composi-
tional,  agronomic and  phenotypic  analyses. 
Guidance is provided on when and how to 
assess  the  toxicity  of  either  the  newly ex-
pressed  protein,  other  constituents  of  the 
GM plant,  or  the whole  GM food or  feed. 
Depending on the scope of the recommended 
study, the FF Guidance refers to the appro-
priate  protocol  for  toxicological  test  accor-
ding to the  OECD (2012b). For the assess-
ment  of  allergenicity,  a  weight-of-evidence 
approach  is  recommended,  and  considera-
tions  are  given  to  the  currently  available 
methods  to  obtain  relevant  data.  With  re-
spect to nutrition,  both the nutritional  rele-
vance of the newly expressed protein(s) and 
any possible  change  in  the levels of endo-
genous constituents of the GM plant should 
be considered in the light of normal dietary 
exposure;  or any intended alteration of use 
of the GM food or feed. On a case-by-case 
basis, guidance is provided on possible live-




The GMO Directive establishes that, once 
a GMO is authorised for marketing, it must 
be monitored  on  a yearly basis.  Therefore, 
applications under the GMO Directive (and 
under  the  GMFF  Regulation  when  culti-
vation is foreseen) must be accompanied by 
a  post-market  environmental  monitoring 
(PMEM)  plan  outlining  how  the  potential 
environmental  effects  of  the  GMO will  be 
monitored.
The PMEM has two objectives:
(1) confirm that  any  assumptions  regarding 
the  occurrence  and  impact  of  potential 
adverse effects of the GMO or its use in 
the ERA are correct;
(2) identify the occurrence of adverse effects 
of the GMO or its use on human health or 
the environment which were not anticip-
ated in the ERA.
The first objective is directly dependent on 
the outcome of the ERA, and therefore is to 
be fulfilled on a case-by-case basis. If, after 
conducting the ERA, there is still significant 
level of uncertainty or risks are identified, a 
case-specific monitoring (CSM) plan needs 
to  be provided.  This CSM will  enable stu-
dies to be conducted on the cultivated plants 
to provide more information on the potential 
risks  identified  in  the  ERA,  to  reduce  the 
level of uncertainty and to evaluate the effi-
ciency  of  any  management  measures  that 
might be applied to minimise the identified 
risks. The second objective is mandatory for 
all GMOs, and requires a strategy for general 
surveillance (GS) of the GMO, once released 
into  the  environment.  The  ERA  Guidance 
Documents and the Guidance on the PMEM 
of GM plants (EFSA 2011b) provide infor-
mation on designing CSM and GS studies in 
order  to  achieve  the  objectives  of  PMEM. 
Plans for CSM are hypothesis-driven based 
on  the  identified  uncertainties  and  know-
ledge gaps of the ERA, and should therefore 
be designed to obtain the necessary data. GS 
is not hypothesis-driven, and therefore more 
difficult to plan. The Guidance proposes GS 
to be considered within a framework of ge-
neral  environmental  protection  monitoring, 
focusing on defined protection goals. Diffe-
rent  tools  and  approaches  to  implement  a 
plan  for  GS are  discussed in  the Guidance 
documents,  starting  from  a  comprehensive 
review of the existing scientific knowledge, 
to  surveys  to  farmers  and  monitoring  sys-
tems for environmental data collection.
Challenges to the RA of GM trees
Although  applications  for  marketing  of 
GM trees in the EU are not expected in the 
near future, it seems that they can be expec-
ted  within  the  next  decade.  Although  GM 
trees will be a novelty in the EU landscape 
of biotechnological applications, the already 
existing EU regulatory system will  provide 
applicants, risk assessors and risk managers 
with  adequate  legislation  and  useful  gui-
dance.  However  some of  the  data  require-
ments for the risk assessments in the EFSA 
guidances have been formulated with a view 
on GM annual  crops,  as these are the sub-
jects of almost all applications already sub-
mitted or expected to be submitted to the EU 
in the near future. However, trees have seve-
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ral characteristics that differ from crop plants 
and can influence some of the data require-
ments  for  the  risk  assessment,  for  which 
more  focused  guidance  might  be  needed. 
Trees are  generally perennial,  woody,  long 
lived  species  with  long  life  cycles  taking 
several  years  to  reach  sexual  maturity  and 
commence reproduction. When mature some 
can produce large amounts of seed and pol-
len  that  can  disperse  over  long  distances 
(Hoenicka & Fladung 2006).
The type and purpose of the tree cultivation 
will influence the specific aspects to be con-
sidered  in  the  ERA,  and  therefore  the  in-
formation requirements. In case of forest and 
plantation  trees,  species  are  not  normally 
“domesticated”  so  that  the  cultivated  types 
can be similar  to  wild  types and  exchange 
genes with them (DiFazio et al. 2004). In ad-
dition, forest trees can come in many forms 
that are adapted to a range of environments. 
They can form pioneer  and climax vegeta-
tions and exist as a range of different com-
ponents in environments. Furthermore, they 
have  complex  interactions  with  a  range  of 
biota often supporting large diverse commu-
nities and food webs (Whitham et al. 2006). 
They also  have  important  roles  in  geogra-
phical  and  physical  features  of  landscapes 
e.g.,  in stabilising hillsides, preventing ero-
sion or influencing microclimates.
In  the  risk  assessment  it  is  important  to 
understand the characteristics of the tree that 
is being transformed and its role in its range 
of  environments.  OECD  (2012a) has  now 
produced descriptions of many of the major 
species,  which  can provide a starting point 
for  this  evaluation.  The  risk  assessment 
should  then  determine  the  impacts  of  the 
newly introduced GM traits on the tree and 
whether the traits will affect any of the envi-
ronmental  interactions  associated  with  the 
non-GM tree or  introduce new interactions 
with biota or receiving environments.
Risk  assessments  will  need  to  carefully 
consider  the  likelihood  of  gene  flow  and 
spread of GM trees into the broader environ-
ment and the consequences for the ecology 
of  potential  receiving  environments  (Hoe-
nicka & Fladung 2006). In doing this,  risk 
assessors will have to consider the time scale 
for  these effects to  occur and may have to 
develop models in order to assess potential 
outcomes (DiFazio et al. 2004, Brunner et al. 
2007, Bialozyt 2012). Some of these factors 
have  also  been  taken  into  consideration  in 
the  risk assessment  of GM trees  under  the 
Cartagena Protocol on Biosafety (see  http:// 
bch.cbd.int/onlineconferences/guidance_ra. 
shtml).
In order to restrict gene flow and manage 
impacts on natural and semi-natural environ-
ments, GM forest trees are most likely to be 
grown in specific plantation systems where 
flowering  and  seeding  are  managed.  How-
ever, the environmental impacts of any new 
cultivation  and  management  systems  will 
need to be assessed and compared with the 
traditional  systems they are  replacing  (Fir-
bank  2008).  In  addition,  GM orchard  fruit 
tree  cultivation  techniques  may also  differ 
from conventional systems and any manage-
ment  changes  require  assessment  for  their 
environmental consequences.
The characteristics of trees  also have im-
plications  for  design  of  field  trials  for  the 
purpose  of  determination  of  the  stable  ex-
pression and heritability of the modified trait 
etc. In addition, the choice of tree compara-
tors and spectrum of available tree varieties 
with  commercial  use may be more limited. 
Therefore, there are methodological challen-
ges to  be solved in  the data generation for 
the ERA such as the number of generations 
needed to test the genetic stability of the in-
serts (Ahuja 2009),  the number and design 
of field trials for compositional, phenotypic, 
protein  expression  analysis  and  environ-
mental impacts, and the use of different va-
rieties  or  provenances  to  estimate  current 
variation in commercial systems.
It is likely that further discussions will be 
needed on the types of studies required for 
providing safety data to be used in the RA of 
GM  trees  and  their  products,  in  order  to 
provide  further  clarifications  and  guidance 
that complements the already existing EFSA 
guidance documents (Fladung et al. 2012).
Conclusions
In  conclusion,  the  current  EU regulatory 
framework  on  GMOs  also  applies  to  GM 
trees. The GM plant guidance documents de-
veloped by EFSA provide useful information 
on  risk  assessment  of  GM trees  for  appli-
cants and risk assessors. However, the bio-
logy of GM fruit  and forest trees and their 
management  practices  may  call  for  some 
changes  in  the  data  types,  collection,  and 
analysis to support the risk assessment. Gi-
ven the long generation time of GM trees, it 
becomes  particularly important  that  hazard 
identification  is  initiated  at  an  early  stage 
and that data are collected that are relevant 
to the time scale of tree life cycles.
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Footnotes
[1] In the EU system, a Directive is a legislation 
whose objectives must be achieved through na-
tional  legislations  developed independently by 
each  Member  State.  In  contrast,  a  Regulation 
sets  out  the  means to  reach its  own objective 
and  does  not  require  any  implementing  mea-
sures at the national level.
© SISEF http://www.sisef.it/iforest/ 131  iForest (2013) 6: 127-131
